GOG Foundation Scholar Investigator Award

GOG Foundation Scholar Investigator Award

The GOG Foundation’s Education/Mentoring Committee in collaboration with the NRG Oncology Early Career New Investigators Committee and the Society of Gynecologic Oncology (SGO) is seeking applications for a five-year GOG Foundation Scholar Investigator Award. The purpose of this award is to identify, enhance, and support training for Scholar Investigators who will be capable and committed to developing, executing, and leading gynecologic oncology clinical trials, conducting high-quality research related to gynecologic cancer, and participating in GOG Foundation/NRG Oncology and other relevant committee/leadership positions.

This five-year award will fund the development of GOG Foundation Scholar Investigators, who have academic or non-academic medical center appointments, as they work to establish an independent clinical cancer research career with a patient-oriented clinical trial research focus in gynecologic cancer within the GOG Foundation and NRG Oncology. Each application should represent the applicant’s research interest(s) and competencies as well as prior clinical trial research training.

Eligibility Criteria

  1. Physicians or scientists with a terminal degree (MD, DO, PhD) who are within 15 years following completion of fellowship or postdoctoral training are eligible.
  2. All eligible applicants should have practice and/or research focus in gynecologic cancer with evidence of scholarly productivity.
  3. Applicants may have been or be a current career development awardee (e.g., K23, K08, or any other type of career development award).
  4. An established mentor is not required for eligibility.

Obligations and Funding

Selected GOG Foundation Scholar Investigators will be:

  1. Required over a period of 5 years to devote at a minimum 10% effort for GOG Foundation/NRG Oncology related gynecologic cancer clinical trial development activities. Funding will be provided for 10% effort at NIH cap with 15% indirect funding in support of this obligation.
  2. Expected to attend the semiannual NRG Oncology meetings from the summer of 2022 through the winter of 2027. A stipend of $1500 will be provided to support registration, travel and hotel expenses for each meeting.
  3. Expected to attend NRG Oncology Early Career New Investigators Committee meetings and NRG Oncology sponsored New Investigator Training Forums during required NRG Oncology semiannual meetings if the scholar has not previously participated in the NRG Oncology Early Career New Investigators Committee or received equivalent new investigator clinical trial training. Application for membership to the NRG Oncology Early Career New Investigators Committee is expected. There are no fees other than meeting registration associated with these activities.
  4. Identify and establish a GOG Foundation/NRG Oncology mentor for the entire award period. An annual stipend of $20,000 will be provided to the mentor.
  5. Be assigned to and actively participate in a GOG Foundation/NRG Oncology disease site or other relevant committee(s).
  6. Expected to work under the guidance of your mentor to develop at least one clinical trial in gynecologic cancer in which the awardee will serve in a major investigator role. Investigator initiated support up to $50,000 will be provided for meritorious proposals in support of clinical trial development.
  7. Expected to develop and participate in ancillary studies and proposals for either NRG Oncology and/or GOG-Partners or NRG Oncology studies.
  8. Pursue membership on a relevant NCI CTEP Task Force and/or as junior member of GCSC.
  9. Expected to attend GOG-Foundation sponsored Symposiums held during required NRG Oncology semiannual meetings. Registration fees will be waived.
  10. Encouraged to attend an ASCO Methods in Clinical Cancer Research Workshop (if not previously attended) and to attend clinical trial workshops and postgraduate courses as available during the 2023 -2028 SGO Annual Meeting on Women’s Cancer. If the scholar has received previous clinical trial training attendance is not required.
  11. Expected to attend meetings focusing on strategic planning of clinical trials in gynecologic cancer. These sessions may include but are not limited to NCI Clinical Trial Planning Meetings, GOG-Foundation Advisory Boards, CTEP Externships, etc. Support for travel for these meetings when not held during the semiannual NRG Oncology meetings will not be provided if not provided by the sponsoring organization.
  12. Pursue independent K or R type funding in support of career development and research activities.
  13. Required to submit an annual progress report including a final report, and budget summary. Continuation of the award will be based upon extent to which obligations were made in the prior year.

GOG Foundation Scholar Investigator Award Application Instructions

  1. Interested applicants should complete the application below, including a cover letter, copy of their CV, and Letter(s) of Support by 5 pm eastern on March 31, 2022.
  2. The cover letter (limit 2 pages) should provide a brief description of the applicant’s research interest(s), competencies, prior research experience, and clinical trial training. The letter should also describe the applicant’s career goals and how this award might facilitate those goals.
  3. If you have an established GOG Foundation or NRG Oncology mentor, please provide a letter of support from your mentor.
  4. A letter of support from a Division Director or Chair should be provided confirming at a minimum 10% protected time to complete obligations of this award.
  5. Up to 3 eligible and meritorious applicants will be selected and notified of award by April 30, 2022.

Application Submission Checklist

  • Application
  • Cover Letter
  • Curriculum Vitae
  • Letter of Support (from GOG or NRG Mentor) if applicable
  • Letter of Support (from Division Director or Chair)

Submissions are now closed. The application deadline has passed.

2019 Recipients

The Scholar Investigator Award identifies Scholar Investigators who are capable of developing, executing, and leading gynecologic oncology clinical trials, conducting high-quality research related to gynecologic cancer, and participating in leadership positions. This five-year award is a collaboration among the GOG Foundation’s Education and Mentoring Committee, the NRG Oncology New Investigator Committee, and the Society of Gynecologic Oncology.

 

Recipients

  • Rebecca Arend, MD – Gynecologic Oncology, UAB
  • Emma Barber, MD – Gynecologic Oncology, Northwestern
  • Lisa Barroilhet, MD – Gynecologic Oncology, Wisconsin
  • Katherine Fuh, MD, PhD – Gynecologic Oncology, Washington University
  • Stephanie Gallaird, MD, PhD – Medical Oncology, Johns Hopkins
  • Lillian Gien, MD – Gynecologic Oncology, Sunnybrook
  • Debra Richardson, MD – Gynecologic Oncology, Oklahoma
  • Ritu Salani, MD – Gynecologic Oncology, Ohio St.
  • Shannon N. Westin, MD, MPH – Gynecologic Oncology, MD Anderson
  • Dmitry Zamarin, MD, PhD – Medical Oncology, Memorial Sloan Kettering

Back to Grants